Onco-Hu Mouse Models for Cancer Immunotherapy Research Explained
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Access the On-Demand Video
Onco-Hu® models are a robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells. The platform is based on NSG™ and NSG™-SGM3 transgenic mice, dually engrafted with human CD34+ hematopoietic stem cells (HSCs) and clinically relevant PDX Live™ low passage tumors. Watch this video to learn more about Onco-Hu® mouse models.